SPT 2 definition

SPT 2 means the reduction of CO2e-emissions Scope 3 (considering the following categories of Scope 3: purchased goods and services, capital goods, use of sold products and downstream leased assets) by at least [SPT 2 Percentage] per cent. compared to the Base Year, subject to any Recalculation, per customer (including mobile, fixed-line, broadband and TV customers but excluding wholesale customers) by [SPT 2 Year].
Sample 1Sample 2Sample 3
SPT 2 means that the Group’s science based target is aligned with the SBTi targets by 31 December 2025 and announced following validation.
Sample 1Sample 2Sample 3
SPT 2 means, in relation to a calendar year ending on 31 December or the SPT 2 Measurement Period, the Emissions Intensity for that calendar year or the SPT 2 Measurement Period.
Sample 1Sample 2Sample 3

Examples of SPT 2 in a sentence

  • Tests conducted to assess the performance of WMA included 1) permanent deformation (rutting) susceptibility by asphalt pavement analyzer (APA) and flow number FN by simple performance tester (SPT), 2) low temperature cracking performance including tensile strength and tensile creep compliance properties by indirect tension test (IDT), 3) moisture susceptibility by moisture induced sensitivity tests (MIST), and 4) dynamic modulus |E*| by SPT.

  • If the Issuer determines, for any reason, that the SPT 2 Calculation Methodology cannot be used, the Issuer must use common industry practice for the purposes of measuring its performance in respect of SPT 2.

  • Subject to paragraph 5(c), for the period from the Issue Date until the SPT 2 Test Date, the Issuer will measure, and will report no later than 90 days following the end of each calendar year, on the Issuer’s performance in respect of SPT 2 for the calendar year ending on the previous 31 December.

  • For this purpose, emissions during the Rectification Period will not be included in the calculation of and measurement of SPT 2.

  • If the SPT 2 for the SPT 2 Measurement Period ending on the SPT 2 Test Date does not equal the SPT 2 Target, a “SPT 2 Trigger Event” occurs.

  • On this basis, we would consider this component of SPT 2 to be aligned with a 1.5-degree scenario and hence also the Paris Agreement goals.Emissions from tenant transport✓ According to the Swedish Climate Policy Council,11 domestic transportation emissions need to decline by 8% per year between 2019-2030 to meet the interim national target of a 70% decline by 2030 from 2010 levels, which is part of Sweden’s goal to be climate neutral by 2045.

  • Summary of key factors beyond the issuers’ direct control that may affect the achievement of SPT 2: Atrium Ljungberg may not be able to achieve SPT 2 if tenants’ behaviours do not change sufficiently in response to its engagement efforts and physical solutions.

  • If the SPT 2 Trigger Event occurs, the SPT 2 Coupon Step-Up Margin will apply from (and including) the first Interest Payment Date following the SPT 2 Test Date.

  • Swabish et al (2006) assembled data to examine the cross-national effects of income inequality and trust on social expenditures.

  • The occurrence of a SPT 2 Trigger Event does not constitute an Event of Default.


More Definitions of SPT 2

SPT 2 means that the Group’s GHG emissions reduction targets are validated and approved science based targets of the SBTi.
Sample 1Sample 2
SPT 2 means cumulative [amount] tons of CO2 emissions avoided via CCUS Technologies by the end of the financial year [relevant year] starting from the beginning of the financial year [baseline year].A "SPT 2 Event" occurs if the Verification Assurance Certificate does not confirm that the cumulative amount for the KPI 2 result by the end of financial year [relevant year] starting from the financial year [baseline year] as shown in the Relevant Determination Report is equal or above the SPT 2 or if no Verification Assurance Certificate is available latest on the Target Reporting Date.The SPT 2 Event shall become effective as of the date of publication of the Verification Assurance Certificate or one Business Day after the Target Reporting Date, whichever occurs earlier.]"
Sample 1Sample 2
SPT 2 means that the Group’s Scope 1, 2 and 3 greenhouse gas emissions reduction targets are validated and approved as science based targets of the SBTi by the end of 2024, and thereafter comply with those annual targets.
Sample 1
SPT 2 means, with respect to any calendar year, the SPT 2 for such calendar year as set forth in the Sustainability Table.
Sample 1
SPT 2 means the year-on-year increase in the number of Contractors placed in Energy Transition/Renewables projects.
Sample 1
SPT 2 means delivering £1,500,000 of Social Value per annum through the Portfolio or Supported Enterprises as determined according to the Social Value Engine.
Sample 1

Related to SPT 2

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Pivotal Clinical Trial means a clinical study of an investigational product in patients with the primary objective of confirming with statistical significance the efficacy and safety with the aim to obtain regulatory approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant regulatory authority in a country other than the United States.

  • Exempt compound means the same as defined in Rule 2.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • IND means an Investigational New Drug Application submitted to the FDA in conformance with applicable laws and regulations, or the foreign equivalent of any such application in any other country.

  • Cannabis testing facility means an entity registered by

  • MI 61-101 means Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions;

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Principal Regulator means the body or person appointed as the Principal Regulator under the Charities Act 2011;